News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
592,979 Results
Type
Article (52820)
Company Profile (139)
Press Release (540012)
Multimedia
Podcasts (109)
Webinars (19)
Section
Business (159084)
Career Advice (2472)
Deals (29477)
Drug Delivery (123)
Drug Development (73030)
Employer Resources (158)
FDA (16195)
Job Trends (12778)
News (285400)
Policy (31007)
Tag
Academia (2675)
Academic (1)
Accelerated approval (16)
Adcomms (33)
Allergies (103)
Alliances (40953)
ALS (118)
Alzheimer's disease (1592)
Antibody-drug conjugate (ADC) (172)
Approvals (16163)
Artificial intelligence (357)
Autoimmune disease (35)
Automation (19)
Bankruptcy (319)
Best Places to Work (9840)
BIOSECURE Act (22)
Biosimilars (138)
Biotechnology (82)
Bladder cancer (106)
Brain cancer (41)
Breast cancer (387)
Cancer (3106)
Cardiovascular disease (271)
Career advice (2079)
Career pathing (33)
CAR-T (207)
CDC (43)
Cell therapy (544)
Cervical cancer (26)
Clinical research (60340)
Collaboration (1053)
Company closure (4)
Compensation (781)
Complete response letters (43)
COVID-19 (2726)
CRISPR (65)
C-suite (396)
Cystic fibrosis (118)
Data (3204)
Decentralized trials (2)
Denatured (22)
Depression (85)
Diabetes (368)
Diagnostics (5806)
Digital health (21)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (146)
Drug pricing (163)
Drug shortages (34)
Duchenne muscular dystrophy (172)
Earnings (63262)
Editorial (52)
Employer branding (21)
Employer resources (142)
Events (86872)
Executive appointments (831)
FDA (18238)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (943)
Gene editing (139)
Generative AI (26)
Gene therapy (442)
GLP-1 (921)
Government (4267)
Grass and pollen (7)
Guidances (321)
Healthcare (16342)
HIV (41)
Huntington's disease (31)
IgA nephropathy (48)
Immunology and inflammation (195)
Immuno-oncology (17)
Indications (39)
Infectious disease (2916)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (72)
Intellectual property (138)
Interviews (454)
IPO (14577)
IRA (56)
Job creations (3291)
Job search strategy (1721)
Kidney cancer (14)
Labor market (56)
Layoffs (577)
Leadership (29)
Legal (7285)
Liver cancer (83)
Longevity (11)
Lung cancer (435)
Lymphoma (232)
Machine learning (16)
Management (53)
Manufacturing (450)
MASH (109)
Medical device (12038)
Medtech (12046)
Mergers & acquisitions (15650)
Metabolic disorders (968)
Multiple sclerosis (97)
NASH (22)
Neurodegenerative disease (153)
Neuropsychiatric disorders (47)
Neuroscience (2359)
NextGen: Class of 2025 (5473)
Non-profit (3861)
Now hiring (29)
Obesity (499)
Opinion (255)
Ovarian cancer (107)
Pain (127)
Pancreatic cancer (132)
Parkinson's disease (193)
Partnered (19)
Patents (341)
Patient recruitment (213)
Peanut (50)
People (48536)
Pharmaceutical (39)
Pharmacy benefit managers (25)
Phase I (18250)
Phase II (26219)
Phase III (20888)
Pipeline (2234)
Policy (267)
Postmarket research (2458)
Preclinical (7658)
Press Release (38)
Prostate cancer (157)
Psychedelics (45)
Radiopharmaceuticals (235)
Rare diseases (550)
Real estate (4779)
Recruiting (63)
Regulatory (22441)
Reports (37)
Research institute (2486)
Resumes & cover letters (409)
Rett syndrome (11)
RNA editing (11)
RSV (58)
Schizophrenia (109)
Series A (156)
Series B (113)
Service/supplier (9)
Sickle cell disease (70)
Special edition (22)
Spinal muscular atrophy (143)
Sponsored (37)
Startups (3098)
State (1)
Stomach cancer (17)
Supply chain (86)
Tariffs (81)
The Weekly (86)
Vaccines (948)
Venture capital (63)
Weight loss (348)
Women's health (42)
Worklife (20)
Date
Today (106)
Last 7 days (502)
Last 30 days (2464)
Last 365 days (29970)
2025 (19607)
2024 (32840)
2023 (36657)
2022 (47136)
2021 (50802)
2020 (48215)
2019 (39442)
2018 (29895)
2017 (29647)
2016 (28242)
2015 (31159)
2014 (24672)
2013 (20661)
2012 (22026)
2011 (22381)
2010 (20542)
Location
Africa (753)
Alabama (63)
Alaska (6)
Arizona (203)
Arkansas (11)
Asia (35207)
Australia (6241)
California (7723)
Canada (2098)
China (658)
Colorado (313)
Connecticut (347)
Delaware (215)
Europe (83740)
Florida (1199)
Georgia (254)
Hawaii (3)
Idaho (43)
Illinois (605)
India (34)
Indiana (327)
Iowa (18)
Japan (238)
Kansas (98)
Kentucky (23)
Louisiana (12)
Maine (67)
Maryland (1068)
Massachusetts (5759)
Michigan (217)
Minnesota (441)
Mississippi (3)
Missouri (92)
Montana (16)
Nebraska (20)
Nevada (87)
New Hampshire (62)
New Jersey (2140)
New Mexico (20)
New York (2116)
North Carolina (1131)
North Dakota (8)
Northern California (3524)
Ohio (226)
Oklahoma (11)
Oregon (30)
Pennsylvania (1618)
Puerto Rico (12)
Rhode Island (27)
South America (1123)
South Carolina (41)
South Dakota (1)
Southern California (2943)
Tennessee (122)
Texas (1172)
United States (28216)
Utah (209)
Virginia (196)
Washington D.C. (75)
Washington State (630)
West Virginia (4)
Wisconsin (75)
592,979 Results for "northwestern memorial s bluhm cardiovascular institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing
August 8, 2025
·
4 min read
Press Releases
Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound
August 28, 2025
·
6 min read
Cardiovascular disease
Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact
Flagship Pioneering’s ProFound Therapeutics will use its proprietary technology to mine the expanded proteome for novel cardiovascular therapeutics. Novartis has promised to pay up to $750 million per target, though it has not specified how many targets it will go after.
June 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
June 11, 2025
·
5 min read
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in development to date” in the competitive Lp(a) space, where drugs are designed to lower the risk of cardiovascular events such as heart attack and stroke.
March 31, 2025
·
2 min read
·
Tristan Manalac
Business
Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery
Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
October 13, 2022
·
4 min read
Diabetes
Lilly’s Mounjaro ‘Good Enough’ in Cardio Trial, Will Seek Expanded Approval
While Eli Lilly’s diabetes blockbuster was non-inferior to its older incretin therapy Trulicity in a highly anticipated Phase III cardiovascular outcomes trial, analysts had hoped for statistical significance in reducing major events such as cardiovascular death, heart attack and stroke.
July 31, 2025
·
2 min read
·
Heather McKenzie
Press Releases
New Novartis ESC data highlights strength of cardiovascular portfolio
August 18, 2025
·
6 min read
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
Inspira Technologies OXY B.H.N Ltd., a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent with Northwestern Memorial Hospital in Chicago, Illinois.
January 2, 2024
·
4 min read
Press Releases
Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study
August 14, 2025
·
5 min read
1 of 59,298
Next
